The cadherin hypothesis of schizophrenia;Die bedeutung der cadherine bei der pathogenese schizophrener erkrankungen

Fortschritte der Neurologie Psychiatrie

Volumn 71, Issue 2, 2003, Pages 84-88

  Grogss J ^a   Grimm, O ^b   Meyer, J ^b   Lesch, K P ^b  

^a Praxis fur Psychiat/Psychotherapie   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN;

ARTICLE; BRAIN MATURATION; CELL ADHESION; GENE LOCATION; HUMAN; PATHOPHYSIOLOGY; PRENATAL DEVELOPMENT; PROTEIN EXPRESSION; SCHIZOPHRENIA;

BRAIN; BRAIN CHEMISTRY; CADHERINS; HUMANS; SCHIZOPHRENIA;

EID: 18844480247     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-37212     Document Type: Article

References (72)

1. Bunney WE. Neurodevelopmental hypothesis of schizophrenia. In: Charney DS; Nestler EJ; Bunney BS, eds. Neurobiology of Mental Illness. Oxford: Oxford University Press, 1999: 225-235
2. Bogerts B. The neuropathology of schizophrenia: Pathophysiological and neurodevelopmental implications., In: Mednick SA; Cannon TD; Barr CE, eds. Fetal neural development and adult schizophrenia. Cambridge: Cambridge University Press, 1991: 153-173
3. Bogerts B. Hirnstrukturelle Untersuchungen an schizophrenen Patienten. In: Lieb K; Riemann D; Berger M, eds. Biologisch-psychiatrische Forschung - Ein Öberblick. Stuttgart: Fischer-Verlag, 1995: 123-144
4. Lieberman J, Bogerts B, Degreef G, Ashtari M, Lantos G, Alvir J. Qualitative assessment of brain morphology in acute and chronic schizophrenia. Am J Psychiatry 1992; 149: 784-791
5. Arnold SE, Trojanowski JQ. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol (Berl) 1996; 92: 217-231
6. Senitz D, Winkelmann E. Morphology of the orbitofrontal cortex in persons with schizophrenic psychoses. A Golgi and electron microscopy study. Psychiatr Neurol Med Psychol (Leipz) 1981; 33: 1-9
7. Andreasen NC, Olsen SA, Dennert JW, Smith MR. Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms. Am J Psychiatry 1982; 139: 297-302
8. Huber G. Chronische Schizophrenie. Synopsis klinischer und neuroradiologischer Untersuchungen an defektschizophrenen Anstaltspatienten. Einzeldarstellungen aus der theoretischen und klinischen Medizin. Heidelberg: Hüthig, 1961
9. Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976; 2: 924-926
10. Walker EF, Lewine RR, Neumann C. Childhood behavioral characteristics and adult brain morphology in schizophrenia. Schizophr Res 1996; 22: 93-101
11. Weinberger DR, Bigelow LB, Kleinman JE, Klein ST, Rosenblatt JE, Wyatt RJ. Cerebral ventricular enlargement in chronic schizophrenia. An association with poor response to treatment. Arch Gen Psychiatry 1980; 37: 11-13
12. Raz S. Structural cerebral pathology in schizophrenia: regional or diffuse? J Abnorm Psychol 1993; 102: 445-452
13. Beckmann H, Lauer M. The human striatum in schizophrenia. II. Increased number of striatal neurons in schizophrenics. Psychiatry Res 1997; 68: 99-109
14. Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, Wu H, Kinon B, Ashtari M. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 1994; 151: 1430-1436
15. Falkai P, Schneider T, Greve B, Klieser E, Bogerts B. Reduced frontal and occipital lobe asymmetry on the CT-scans of schizophrenic patients. Its specificity and clinical significance. J Neural Transm Gen Sect 1995; 99: 63-77
16. Beckmann H, Jakob H. Pränatale Entwicklungsstörungen von Hirnstrukturen bei schizophrenen Psychosen. Nervenarzt 1994; 65: 454-463
17. Goldman-Rakic P. Cerebral cortical mechanisms in schizophrenia. Neuropsychopharmacol 1994; 10: 22-27
18. Jakob H, Beckmann H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 1986; 65: 303-326
19. Jakob H, Beckmann H. Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics. Pathogenetic and clinical aspects. J Neural Transm Gen Sect 1994; 98: 83-106
20. Papez JW. A proposed mechanism of emotion. Arch Neurol Psychiat 1937; 38: 725-743
21. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660-669
22. Lieberman JA. Pathophysiologic mechanisms in the pathogenesis and clinical course of Schizophrenia. J Clin Psychiatry 1999; 60 (suppl 12): 9-12
23. Colman DR. Cell Adhesion Molecules. In: Siegel GJ; Agranoff BW; Albers RW et al., eds, translator and editor Basic Neurochemistry. Philadelphia: Lippincott Williams & Wilkins, 1999: 139-153
24. Cunningham BA. Cell adhesion molecules as morphoregulators. Curr Opin Cell Biol 1995; 7: 628-633
25. Müller WA, Hassel M. Entwicklungsbiologie der Tiere und des Menschen. In: translator and editor. Berlin Heidelberg New York: Springer-Verlag, 1999: 349-352
26. Takeichi M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 1988; 102: 639-655
27. Steinberg MS, McNutt PM. Cadherins and their connections: adhesion junctions have broader functions. Curr Opin Cell Biol 1999; 11: 554-560
28. Tepass U. Genetic analysis of cadherin function in animal morphogenesis. Curr Opin Cell Biol 1999; 11: 540-548
29. Vogel G. Tracking the movements that shape an embryo. Science 2000; 288: 86-87
30. Steinberg MS. Does differential adhesion govern self-assembly processes in histogenesis? Equilibrium configurations and the emergence of a hierarchy among populations of embryonic cells. J Exp Zool 1970; 173: 395-434
31. Wolpert L. Principles of development. In: translator and editor. Oxford: Oxford University Press, 1998: 232-235
32. Gumbiner BM, Yamada KM. Cell-to-cell contact and extracellular matrix. Curr Opin Cell Biol 1995; 7: 615-618
33. Redies C. Cadherins in the central nervous system. Prog Neurobiol 2000; 61: 611-648
34. Fawcett JW, Keynes RJ. Peripheral nerve regeneration. Annu Rev Neurosci 1990; 13: 43-60
35. Nollet F, Kools P, Roy Fvan. Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol 2000; 299: 551-572
36. Yagi T, Takeichi M. Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. Genes & Dev 2000; 14: 1169-1180
37. Koch PJ, Franke WW. Desmosomal cadherins: another growing multigene family of adhesion molecules. Curr Opin Cell Biol 1994; 6: 682-687
38. Dunne J, Hanby AM, Poulsom R, Jones TA, Sheer D, Chin WG, Da SM, Zhao Q, Beverley PC, Owen MJ. Molecular cloning and tissue expression of FAT, the human homologue of the Drosophila fat gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule. Genomics 1995; 30: 207-223
39. Sano K, Tanihara H, Heimark RL, Obata S, Davidson M, St John T, Taketani S, Suzuki S. Protocadherins: a large family of cadherin-related molecules in central nervous system. Embo J 1993; 12: 2249-2256
40. Wu Q, Maniatis T. Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. Proc Natl Acad Sci USA 2000; 97: 3124-3129
41. Kohmura N, Senzaki K, Hamada S, Kai N, Yasuda R, Watanabe M, Ishii H, Yasuda M, Mishina M, Yagi T. Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. Neuron 1998; 20: 1137-1151
42. Senzaki K, Ogawa M, Yagi T. Proteins of the CNR family are multiple receptors for Reelin. Cell 1999; 99: 635-647
43. Del Rio JA, Heimrich B, Borrell V, Forster E, Drakew A, Alcantara S, Nakajima K, Miyata T, Ogawa M, Mikoshiba K. A role for Cajal-Retzius cells and reelin in the development of hippocampal connections. Nature 1997; 385: 70-74
44. D'Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI, Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 1995; 374: 719-723
45. Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, Uzunov DP, Smalheiser NR, Davis JM, Pandey GN, Pappas GD, Tueting P, Sharma RP, Costa E. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci U S A 1998; 95: 15718-15723
46. Ishizaka Y, Itoh F, Tahira T, Ikeda I, Sugimura T, Tucker J, Fertitta A, Carrano AV, Nagao M. Human ret proto-oncogene mapped to chromosome 10q11.2. Oncogene 1989; 4: 1519-1521
47. Formstone CJ, Barclay J, Rees M, Little PF. Chromosomal localization of Celsr2 and Celsr3 in the mouse; Celsr3 is a candidate for the tippy (tip) lethal mutant on chromosome 9. Mamm Genome 2000; 11: 392-394
48. Hadjantonakis AK, Formstone CJ, Little PFR. mCelsr1 is an evolutionarily conserved seven-pass transmembrane receptor and is expressed during mouse embryonic development. Mech Dev 1998; 78: 91-95
49. Hadjantonakis AK, Sheward WJ, Harmar AJ, de Galan L, Hoovers JM, Little PF. Celsr1, a neural-specific gene encoding an unusual seven-pass transmembrane receptor, maps to mouse chromosome 15 and human chromosome 22qter. Genomics 1997: 45: 97-104
50. Nakayama M, Nakajima D, Nagase T, Nomura N. Seki N, Ohara O. Identification of high-molecular-weight proteins with multiple EGF-like motifs by motif-trap screening. Genomics 1998; 51: 27-34
51. Gao FB. Brenman JE, Jan LY, Jan YN. Genes regulating dendritic outgrowth, branching, and routing in Drosophila. Genes & Dev 1999; 13: 2549-2561
52. Usui T, Shima Y, Shimada Y, Hirano S, Burgess RW, Schwarz TL, Takeichi M, Uemura T. Flamingo, a seven-pass transmembrane cadherin, regulates planar cell polarity under the control of Frizzled. Cell 1999; 98: 585-595
53. Coughlin SR. Expanding horizons for receptors coupled to G proteins: diversity and disease. Curr Opin Cell Biol 1994; 6: 191-197
54. Linder ME, Gilman AG. G-Proteine. Spektrum der Wissenschaft 1992; 9: 54-62
55. Dhanasekaran N, Tsim ST, Dermott JM, Onesime D. Regulation of cell proliferation by G proteins. Oncogene 1998; 17: 1383-1394
56. Gutkind JS. Cell growth control by G protein-coupled receptors: from signal transduction to signal integration. Oncogene 1998; 17: 1331-1342
57. Lindsay EA, Morris MA, Gos A, Nestadt G, Wolyniec PS, Lasseter VK, Shprintzen R, Antonarakis SE, Baldini A, Pulver AE. Schizophrenia and chromosomal deletions within 22q11.2. Am J Hum Genet 1995; 56: 1502-1503
58. Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, Nestadt G, Antonarakis S, Housman D, Kazazian HH, Meyers D et al. Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: Part 1. Am J Med Genet 1994; 54: 36-43
59. Pulver AE, Karayiorgou M, Lasseter VK, Wolyniec P, Kasch L, Antonarakis S, Housman D, Kazazian HH, Meyers D, Nestadt G et al. Follow-up of a report of a potential linkage for schizophrenia on chromosome 22q12-q13.1: Part 2. Am J Med Genet 1994; 54: 44-50
60. Stoeber G, Saar K, Rüschendorf F, Meyer J, Nürnberg G, Jatzke S, Franzek E, Reis A, Lesch K-P, Wienker TF, Beckmann H. Splitting schizophrenia: periodic catatonia- susceptibility locus on chromosome 15q15. Am J Hum Genet 2000; 67: 1201-1207
61. Barden N, Morissette J. Chromosome 13 workshop report. Am J Med Genet 1999; 88: 260-262
62. Crowe RR, Vieland V. Report of the Chromosome 5 Workshop of the Sixth World Congress on Psychiatric Genetics. Am J Med Genet 1999; 88: 229-232
63. Riley BP, Lin MW, Mogudi-Carter M, Jenkins T, Williamson R, Powell JF, Collier D, Murray R. Failure to exclude a possible schizophrenia susceptibility locus on chromosome 13q14.1-q32 in southern African Bantu-speaking families. Psychiatr Genet 1998; 8: 155-162
64. Schwab SG, Eckstein GN, Hallmayer J, Lerer B, Albus M, Borrmann M, Lichtermann D, Ertl MA, Maier W, Wildenauer DB. Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry 1997; 2: 156-160
65. Van Broeckhoven C, Verheyen G. Report of the chromosome 18 workshop. Am J Med Genet 1999; 88: 263-270
66. Maier W, Schwab S, Rietschel M. Genetik funktioneller psychischer Störungen. In: Möller HJ, ed., translator and editor Psychiatrie und Psychotherapie. Berlin Heidelberg New York: Springer-Verlag, 2000: 69-101
67. Leonhard K. Aufteilung der endogenen Psychosen und ihre differenzierte Atiologie. Stuttgart New York: Georg Thieme Verlag, 1995
68. Nesslinger NJ, Gorski JL, Kurczynski TW, Shapira SK, Siegel-Bartelt J, Dumanski JP, Cullen Jr RF, French BN, McDermid HE. Clinical, cytogenetic, and molecular characterization of seven patients with deletions of chromosome 22q13.3. Am J Hum Genet 1994; 54: 464-472
69. Gross J, Grimm O, Ortega G, Mössner R, Riederer P, Meyer J, Lesch K-P. Allelic Variants of the human CELSR1 cadherin gene. Eur Arch Psychiatry Clin Neurosci 2000; 250: 40
70. Gross J, Grimm O, Ortega G, Teuber I, Lesch K-P, Meyer J. Mutational analysis of the neuronal cadherin gene CELSR1 and exclusion as a candidate for catatonic schizophrenia in a large family. Psychiatr Genet 2001; 11: 197-200
71. Teicher LS, Caspari EW. The genetics of blind - a lethal factor in mice. J Hered 1978; 69: 86-90
72. Watson ML. Blind - a dominant mutation in mice. J Hered 1968; 59: 60-64